Program Pengabdian Masyarakat: Edukasi dan Deteksi Dini Kanker Serviks melalui Pemeriksaan Pap Smear di Kecamatan Bangkalan
DOI:
https://doi.org/10.59837/jpmba.v3i3.2310Keywords:
pap smear, deteksi dini, kanker serviks, pencegahan, pelatihan tenaga kesehatanAbstract
Kegiatan pengabdia masyarakat ini bertujuan untuk meningkatkan pemahaman tenaga kesehatan dan masyarakat mengenai deteksi dini serta pencegahan kanker serviks. Pelatihan tenaga kesehatan dilakukan agar mereka dapat melakukan prosedur Pap smear dengan benar dan sesuai standar, sementara penyuluhan masyarakat bertujuan untuk meningkatkan kesadaran akan pentingnya deteksi dini dan pencegahan kanker serviks. Studi ini menggunakan metode deskriptif observasional dengan pendekatan cross-sectional, mencakup dua kegiatan utama: pelatihan tenaga medis secara daring dan penyuluhan masyarakat secara langsung. Pelatihan Pap smear diikuti oleh 51 peserta yang terdiri dari perawat, bidan, dan dokter. Evaluasi sebelum dan sesudah pelatihan menunjukkan peningkatan pemahaman yang signifikan, di mana peserta dengan skor 80-100 meningkat dari 58,82% menjadi 82,35%. Penyuluhan kanker serviks diikuti oleh 74 peserta. Sebelum penyuluhan, hanya 12,16% peserta yang memperoleh nilai 80-100, namun setelahnya meningkat menjadi 100%. Sebanyak 62,2% peserta telah menikah, 8,1% memiliki riwayat hubungan seksual sebelum usia 17 tahun, dan 9,5% memiliki lebih dari satu pasangan. Selain itu, 98,6% belum pernah menerima vaksin HPV, dan 78,4% jarang melakukan Pap smear, menunjukkan rendahnya kesadaran pencegahan kanker serviks. Setelah penyuluhan, 60 peserta menjalani skrining kanker serviks. Mayoritas (41,7%) berusia 31-40 tahun. Hasil skrining dengan sistem Bethesda menunjukkan 100% NILM. Berdasarkan klasifikasi Papanicolaou, 88,1% termasuk kelas II (96,2% inflamasi, 1,9% bacterial vaginosis, 1,9% atrofi), dan 11,1% kelas I. Program ini terbukti efektif dalam meningkatkan pemahaman tenaga kesehatan dan masyarakat, serta keterampilan tenaga kesehatan dalam prosedur Pap smear, yang berkontribusi pada peningkatan kualitas layanan deteksi dini kanker serviks di RSIA Hikmah Sawi Bangkalan.
Downloads
References
Anastasiou, E., McCarthy, K. J., Gollub, E. L., Ralph, L., van de Wijgert, J. H. H. M., & Jones, H. E. (2022). The relationship between hormonal contraception and cervical dysplasia/cancer controlling for human papillomavirus infection: A systematic review. Contraception, 107, 1–9. https://doi.org/10.1016/j.contraception.2021.10.018
Basoya, S., & Anjankar, A. (2022). Cervical Cancer: Early Detection and Prevention in Reproductive Age Group. Cureus, 14(11), e31312. https://doi.org/10.7759/CUREUS.31312
Lee, J. E., Chung, Y., Rhee, S., & Kim, T. H. (2022). Untold story of human cervical cancers: HPV-negative cervical cancer. BMB reports, 55(9), 429–438. https://doi.org/10.5483/BMBRep.2022.55.9.042
Liang, L. A., Einzmann, T., Franzen, A., Schwarzer, K., Schauberger, G., Schriefer, D., Radde, K., Zeissig, S. R., Ikenberg, H., Meijer, C. J. L. M., Kirkpatrick, C. J., Kölbl, H., Blettner, M., & Klug, S. J. (2021). Cervical Cancer Screening: Comparison of Conventional Pap Smear Test, Liquid-Based Cytology, and Human Papillomavirus Testing as Stand-alone or Cotesting Strategies. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 30(3), 474–484. https://doi.org/10.1158/1055-9965.EPI-20-1003
Massad, L. S., Einstein, M., Myers, E., Wheeler, C. M., Wentzensen, N., & Solomon, D. (2009). The impact of human papillomavirus vaccination on cervical cancer prevention efforts. Gynecologic Oncology, 114(2), 360. https://doi.org/10.1016/J.YGYNO.2009.04.005
Molina, M. A., Steenbergen, R. D. M., Pumpe, A., Kenyon, A. N., & Melchers, W. J. G. (2024). HPV integration and cervical cancer: a failed evolutionary viral trait. Trends in molecular medicine, 30(9), 890–902. https://doi.org/10.1016/j.molmed.2024.05.009
Ong, Sok King & Abe, Sarah & Thilagaratnam, Shyamala & Haruyama, Rei & Pathak, Ruchi & Jayasekara, Harindra & Togawa, Kayo & K C Bhandari, Aliza & Shankar, Abhishek & Nessa, Ashrafun & Jugder, Uranbolor & Agustina, Julyanti & Biglari, Mohammad & Yusuf, Aasim & Tshomo, Ugyen & Fernando, Eshani & Cairo, Clarito & Kaung, Kyaw & Rath, Beauta & Hwang, William. (2023). Towards elimination of cervical cancer - human papillomavirus (HPV) vaccination and cervical cancer screening in Asian National Cancer Centers Alliance (ANCCA) member countries. The Lancet regional health. Western Pacific. 39. 100860. 10.1016/j.lanwpc.2023.100860.
Rahaju, A. S., Rahniayu, A., Kurniasari, N., Fauziah, D., Kusumastuti, E. H., Mastutik, G., W., D. S. A., Soraya, F., & Ilmiah, K. (2023). Early Detection Of Cervical Cancer And Pap Smear Adequacy At Puskesmas Pilangkencen, Madiun District. Jurnal Layanan Masyarakat (Journal of Public Services), 7(1), 100–113. https://doi.org/10.20473/jlm.v7i1.2023.100-113
Rahangdale, L., Mungo, C., O'Connor, S., Chibwesha, C. J., & Brewer, N. T. (2022). Human papillomavirus vaccination and cervical cancer risk. BMJ (Clinical research ed.), 379, e070115. https://doi.org/10.1136/bmj-2022-070115
Rayner, M., Welp, A., Stoler, M. H., & Cantrell, L. A. (2023). Cervical Cancer Screening Recommendations: Now and for the Future. Healthcare (Basel, Switzerland), 11(16), 2273. https://doi.org/10.3390/healthcare11162273
Sengupta, Sandip & Pal, Rupsha & Samaddar, Dwaipayan & Samaddar, Jaya & Goswami, Bidyut. (2024). Comparative analysis of different cervical screening methods with special reference to the WHO recommended human papillomavirus detection at a rural tertiary care center - A pilot study. Asian Journal of Medical Sciences. 15. 178-183. 10.3126/ajms.v15i2.60320
Shen, Y., Xia, J., Li, H., Xu, Y., & Xu, S. (2021). Human papillomavirus infection rate, distribution characteristics, and risk of age in pre- and postmenopausal women. BMC Women’s Health, 21(1). https://doi.org/10.1186/S12905-021-01217-4
Sherris, J., Herdman, C., & Elias, C. (2001). Cervical cancer in the developing world. Western Journal of Medicine, 175(4), 231. https://doi.org/10.1136/EWJM.175.4.231
Smith, J. S., Green, J., Berrington De Gonzalez, A., Appleby, P., Peto, J., Plummer, M., Franceschi, S., & Beral, V. (2003). Cervical cancer and use of hormonal contraceptives: a systematic review. Lancet, 361(9364), 1159–1167. https://doi.org/10.1016/S0140-6736(03)12949-2
Tekalegn, Y., Sahiledengle, B., Woldeyohannes, D., Atlaw, D., Degno, S., Desta, F., Bekele, K., Aseffa, T., Gezahegn, H., & Kene, C. (2022). High parity is associated with increased risk of cervical cancer: Systematic review and meta-analysis of case–control studies. Women’s Health, 18, 17455065221075904. https://doi.org/10.1177/17455065221075904
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Aditya Sita Sari, Nila Kurniasari, Anny Setijo Rahaju, Alphania Rahniayu, Gondo Mastutik, Dyah Fauziah, Etty Hary Kusumastuti, Willy Sandhika, Priangga Adi Wiratama, Grace Ariani, Ridholia Ridholia, Heriyawati Heriyawati, I Ketut Sudiana, Khafidhotul Ilmiah, Ana Qonitatillah

This work is licensed under a Creative Commons Attribution 4.0 International License.